# A Study of LY3375880 in Healthy Participants

> **NCT03343587** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3375880 IV
- **DRUG:** LY3375880 SC
- **DRUG:** Placebo IV
- **DRUG:** Placebo SC

## Key facts

- **NCT ID:** NCT03343587
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-17
- **Primary completion:** 2018-11-16
- **Final completion:** 2018-11-16
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03343587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03343587, "A Study of LY3375880 in Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03343587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*